Wierda, Keimpe D. B.
Toft-Bertelsen, Trine L.
Gøtzsche, Casper R.
Pedersen, Ellis
Korshunova, Irina
Nielsen, Janne
Bang, Marie Louise
Kønig, Andreas B.
Owczarek, Sylwia
Gjørlund, Michelle D.
Schupp, Melanie
Bock, Elisabeth
Sørensen, Jakob B.
Funding for this research was provided by:
FP7 People: Marie-Curie Actions
FP7 Ideas: European Research Council (201600 Memstick, HEALTH-F2-2009-242167)
European Cooperation in Science and Technology (BM1001)
Lundbeckfonden (R28-2008-1976, R183-2014-3274, R221-2016-1202)
Independent Research Fund Denmark (12-127474, 6110-00354B, 8020-00228A)
Novo Nordisk Fonden (108713, NNF16OC0021198)
Article History
Received: 29 June 2020
Accepted: 8 October 2020
First Online: 22 October 2020
Competing interests
: E.B. is shareholder of Neoloch Aps, which was a partner of the FP7 European Union collaborative project MemStick. This does not alter the authors’ adherence to all policies on sharing data and materials. All other authors declare not having any competing financial interests. This work was supported by grants from the Lundbeck Foundation, the Lundbeck Foundation Center for Biomembranes in Nanomedicine, the Independent Research Fund Denmark, the Novo Nordisk Foundation, FP7 European Union collaborative project MemStick (Grant Agreement No. 201600), large integrating project “SynSys” (Grant Agreement HEALTH-F2-2009-242167) and the COST action BM1001 “Brain Extracellular Matrix in Health and Disease”.